I would take issue with this and argue that from a clinician's noint of view the ma;n advantage of a multicentre report is that it underlines the range of the results which are obtained. Thus Snowden and Williams3 found with the Dalkon Shield a pregnancy rate per 100 users after nine months of use wVhich varied between 0-8 and 8-4. Likewise, Tietze and Lewit,2 studying the T Cu 200 device in nine clinics found an overall pregnancy rate of 2-2 per 100 users, but at one centre the rate was 11-8. 
